【レポートの概要（一部）】
1. Report Overview
1.1 Global Overview of the Checkpoint Inhibitor Anti-Cancer Treatment Market 2015
1.2 Benefits of This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of the Study
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to the Checkpoint Inhibitor Anti-Cancer World Market 2015
2.1 Checkpoint Inhibitors: A New Era in Immunotherapy
2.2 Checkpoint Inhibitor Drug Treatments in Oncology
3. Leading Checkpoint Inhibitors: Anti-Cancer Drug Forecasts 2016-2026 and Leading Companies in the World Market
3.1 Leading Checkpoint Inhibitor Anti-Cancer Drug Treatments on the Market in 2015
3.1.1 Yervoy (ipilimumab) – Bristol-Myers Squibb
3.1.1.1 Yervoy: Sales Analysis
3.1.2 Opdivo (nivolumab) – Bristol-Myers Squibb/Ono Pharmaceutical
3.1.2.1 Opdivo: Sales Analysis
3.1.3 Keytruda (pembrolizumab) – Merck & Co.
3.1.3.1 Keytruda: Sales Analysis
3.2 Leading Companies in the Checkpoint Inhibitor Anti-Cancer Treatment Market in 2015
3.2.1 Bristol-Myers Squibb Leads the Market
4. Checkpoint Inhibitor Anti-Cancer Treatment: World Market 2016-2026
4.1 The Global Market for Checkpoint Inhibitor Anti-Cancer Treatments in 2014
4.2 The World Anti-Cancer Checkpoint Inhibitor Market: Revenue Forecasts 2015-2026
4.3 Leading Checkpoint Inhibitor Treatment Submarkets Forecast 2016-2026
4.3.1 The CTLA-4 Inhibitors Submarket Forecast 2016-2026
4.3.2 The PD-1 Inhibitors Submarket Forecast 2016-2026
4.3.3 Changing Market Shares: PD-1 Inhibitors Will Lead the Market
4.3.4 Drivers and Restraints of the Checkpoint Inhibitor Anti-Cancer Treatment Market 2016-2026
4.3.4.1 Drivers of the Checkpoint Inhibitor Anti-Cancer Treatment Market
4.3.4.2 Restraints of the Checkpoint Inhibitor Anti-Cancer Treatment Market
5. Leading National Markets for the Checkpoint Inhibitor Anti-Cancer Treatment Market 2016-2026
5.1 Regional Breakdown of the World Checkpoint Inhibitor Anti-Cancer Treatments Market 2014-2015
5.2 World Checkpoint Inhibitor Anti-Cancer Treatment Market: Regional Forecast 2016-2026
5.2.1 How Will Regional Market Shares Change to 2026?
5.3 The US Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4 The EU Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4.1 Germany: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4.2 France: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4.3 Italy: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4.4 The UK: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.4.5 Spain: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.5 Japan: The Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
5.6 The APAC Market: Checkpoint Inhibitor Anti-Cancer Treatment Market Forecast 2016-2026
6. The Checkpoint Inhibitor Anti-Cancer Treatment Market Pipeline Analysis 2016-2026
6.1 Anti-PD-1 Inhibitors and Anti-PD-L1 Inhibitors
6.1.1 Atezolizumab (MPDL3280A/RG7446) – Roche/Genentech
6.1.2 Durvalumab (MEDI4736) – AstraZeneca/MedImmune
6.1.3 Avelumab – (MSB0010718C) – Merck KGaA/Pfizer
6.1.4 Pidilizumab (CT-011) – CureTech Ltd
6.1.5 AMP-224 – GSK/Amplimmune
6.1.6 TSR-042 – TESARO Bio/AnaptysBio
6.1.7 AMP-514 (MEDI0680) – AstraZeneca/MedImmune
6.1.8 REGN2810 – Regeneron/Sanofi
6.2 CTLA-4 Inhibitors
6.2.1 Tremelimumab (CP-675,206) – AstraZeneca
6.3 LAG-3 (lymphocyte activation gene-3) Inhibitors
6.3.1 IMP321- Prima Biomed
6.3.2 BMS-986016 – Bristol-Myers Squibb
6.3.3 IMP701 – Prima BioMed/Novartis
6.4 KIR Inhibitors
6.4.1 Lirilumab (IPH2102/BMS-986015) – Innate Pharma/Bristol-Myers Squibb
6.5 Anti-NKG2A Inhibitors
6.5.1 IPH2201 – Innate Pharma/AstraZeneca/MedImmune
6.6 Other Checkpoint Inhibitors
6.6.1 VISTA Inhibitors
6.6.1.1 CA-170 – Curis/Aurigene
6.6.2 IDO and TDO Inhibitors
6.6.2.1 Indoximod (NLG-9189) – NewLink Genetics
6.6.2.2 NLG919 – NewLink Genetics
6.6.2.3 INCB024360 – Incyte/Roche
6.6.3 A2aR Inhibitors
6.6.3.1 HTL-1071 – AstraZeneca/Heptares
6.6.4 Future Areas of Pipeline Research
7. Qualitative Analysis of the Checkpoint Inhibitor Anti-Cancer Treatment Market 2016-2026
7.1 SWOT Analysis of the Checkpoint Inhibitor Anti-Cancer Treatment Market 2016-2026
7.2 Strengths and Weaknesses of the Checkpoint Inhibitor Anti-Cancer Treatment Market
7.2.1 A Novel Treatment Method that Harnesses the Immune System’s Vast Potential
7.2.2 Pricing of the Treatments Will Attract Companies
7.2.3 Cost of Treatment Will Restrain Market Access
7.2.4 Side Effects May Prohibit Growth
7.3 Opportunities and Threats for the Checkpoint Inhibitor Anti-Cancer Treatment Market
7.3.1 Biomarkers Pave the Way for Optimum Utility
7.3.2 Combination Therapies Are Achieving Superior Results
7.3.3 The Cost Burden of Expensive Drug Treatments on Healthcare Systems
7.3.4 Crowding of the Market With Similar Products
8. Research Interviews
8.1 Interview with Dr Nicolai Wagtmann, PhD, Chief Scientific Officer, Innate Pharma, Marseille, France
8.1.1 Innate Pharma’s Immunotherapy Portfolio
8.1.2 The Advantages and Mechanisms Used by Checkpoint Inhibitors
8.1.3 The Disadvantages of Checkpoint Inhibitors
8.2 Interview with Dr. Frédéric Triebel, CFO/CSO of Prima Biomed, Founder of Immutep
8.2.1 LAG-3 Inhibitors: An Upcoming Area of Checkpoint Inhibitor Research
8.2.2 Advantages and Disadvantages of LAG-3 Inhibitors on the Checkpoint Inhibitor Market
8.2.3 The Future Direction of the Checkpoint Inhibitor Market for Prima Biomed
9. Conclusions
9.1 The Global Checkpoint Inhibitor Anti-Cancer Treatment Market: Current World Outlook
9.1.1 Driver for Growth: A Robust and Innovative Pipeline for the Checkpoint Inhibitors Anti-Cancer Treatment Market to 2026
9.2 Leading National Markets for the Checkpoint Inhibitor Anti-Cancer Treatment Market 2016-2026: The US and EU Will Retain Their Lead
9.3 The Future of the Checkpoint Inhibitor Anti-Cancer Treatment Market
【レポート販売概要】
■ タイトル：がん治療用チェックポイント阻害薬の世界市場：CTLA-4阻害薬、PD-1阻害薬■ 英文：Checkpoint Inhibitors for Treating Cancer: Market Report with Forecasts 2016-2026
■ 発行日：2015年12月
■ 調査会社：visiongain
■ 商品コード：VGAIN5122113
■ 調査対象地域：グローバル
- フィールドサービス管理（FSM）ソフトウェアの世界市場2016-2020About Field Service Management Software FSM software enables the scheduling, allocating, and dispatching technicians for field work, and remotely locating, tracking, and managing the staff and processes. The high management visibility in field operations allows enterprises to quickly recognize and address revenue-generating opportunities. It also helps in prioritizing the allotted work, matching t …
- 世界のワクチン製造技術およびサービス市場（2014-2024）Vaccine manufacturing technology and services - your guide to trends and revenue prospects for vaccine production What's the outlook for producing vaccines? Visiongain's brand new report shows you the potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 205 page report provides 104 tables, charts, and graphs. Discover the most lucrative areas in the industry a …
- 世界の印刷用紙＆筆記用紙市場：種類別、地域別Global Printing and Writing Paper Market: About this market Technavio’s printing and writing paper market analysis considers sales from both printing paper and writing paper types. Our study also finds the sales of printing and writing paper in APAC, Europe, MEA, North America, and South America. In 2019, the printing paper segment had a significant market share, and this trend is expected to cont …
- 複合樹脂の世界市場：熱硬化性樹脂、熱可塑性樹脂The composite resin market, in terms of value, is projected to reach around USD 12,885.5 Million by 2020, growing at a CAGR of 5.6% between 2015 and 2020. The global market has witnessed a strong growth in the past few years. This growth is estimated to continue in the coming years. Composite resin has already recognized its value in various end-use applications, the current challenge is to make i …
- 風力タービン用複合材料の世界市場ABSTRACTAbout Wind Turbine Composite Materials The global fossil fuel dependency is expected to cause significant social and economic fluctuations. An economy that is based on fossil fuel is highly unsustainable. The efforts taken to reduce such an impact and reduce its usage and dependence has paved way for alternate and renewable sources of energy. Alternate sources, such as wind energy, is one …
- Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)：グローバル臨床試験レビューH2, 2013Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2013" provides data on the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) clinical trial scenario. This report provides …
- 世界の電気電子機器廃棄物（E-waste）収集サービス市場動向（2012-2016）TechNavio's analysts forecast the Global Collection Services market in the E-waste industry to grow at a CAGR of 14.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of initiatives taken for e-waste collection. The Global Collection Services market in the E-waste industry has also been witnessing an increase in the number of go …
- 飼料用色素のグローバル市場動向（～2018）The feed pigment market is flourishing due to the increasing use of feed in the livestock industry. The leading companies in the feed pigment market are continuously adopting new technologies for manufacturing these feed pigments. The leading feed pigment manufacturers are increasingly using feed pigments for supplementing the diet of animals. The market for carotenoids as pigments was the largest …
- 浮体式生産貯蔵積出設備（FPSO）の世界市場予測（～2024年）The floating production storage and offloading market is projected to reach USD 26.0 billion by 2024, recording a CAGR of 5.9% from 2019 to 2024 The floating production storage and offloading market is projected to reach USD 26.0 billion by 2024 from an estimated USD 19.5 billion in 2019, recording a CAGR of 5.9% during the forecast period. Increase in the deep- and ultra-deepwater oil & gas produ …
- 冠動脈狭窄：治療薬の治験動向（2014年下半期）Coronary Stenosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Stenosis. It includes an overview of the trial numbers and their recruitment s …
- 膝置換術用機器の世界市場2017-2021About Knee Replacement Devices Knee replacement is a surgical procedure, which is performed to replace a damaged part of the knee through knee replacement devices. This procedure is generally performed on patients with osteoarthritis, rheumatoid arthritis, and obesity-related knee problems. Technavio’s analysts forecast the global Knee Replacement Devices market to grow at a CAGR of 3.25% during t …
- 導電性テキスタイルの世界市場展望2017-2026According to Stratistics MRC, the Global Conductive Textiles Market is accounted for $1.07 billion in 2017 and is expected to reach $4.65 billion by 2026 growing at a CAGR of 17.7% during the forecast period. Factors such as growing awareness of the advantages of conductive textiles, high demand from the military & defense sector and Increased health awareness among consumers are fuelling the mark …
- 非アルコール性脂肪肝炎（NASH）治療薬の世界市場2016-2020About Non-Alcoholic Steatohepatitis (NASH) NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of u …
- 中東・アフリカの大人用おむつ市場About Adult DiapersThe adult diaper market in MEA is still in its nascent stage. The social stigma related to adult diapers is still prevalent in this region. Adults diagnosed with urinary incontinence often feel embarrassed to wear diapers and are uncomfortable discussing their problems with physicians. However, manufacturers are collaborating with hospitals in the region to educate consumers abo …
- 世界のデータガバナンス市場：コンポーネント別、展開モデル別、組織規模別、用途別（リスク管理、インシデント管理、コンプライアンス管理）、業種別（製造、ヘルスケア、BFSI）、地域別The global data governance market size to grow at a CAGR of 21.5% during the forecast period The data governance market size is projected to grow from USD 1.8 billion in 2019 to USD 4.8 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 21.5% during the forecast period. The data governance market is driven by growing regulatory compliance and privacy concerns for data security. However, t …
